ATLANTA, GA – – (Businesswire – August 15, 2019) – – Holzer & Holzer, LLC is investigating whether certain statements made by Harrow Health, Inc. (“Harrow Health” or the “Company”) (NASDAQ: HROW) complied with federal securities laws. On August 14, 2019, Harrow Health filed a form 10-Q with the SEC that disclosed its Park facility in California is required to surrender its California pharmacy license by August 27. The price of Harrow Health stock fell following the announcement. If you purchased shares of Harrow Health and suffered a loss on that investment, you are encouraged to contact Corey D. Holzer, Esq. at firstname.lastname@example.org or Luke R. Kennedy at email@example.com, or by toll-free telephone at (888) 508-6832 to discuss your legal rights.